Revival of anti-angiogenic therapies in cancer—news on an old therapeutic concept
Sign Up to like & getrecommendations! Published in 2017 at "memo - Magazine of European Medical Oncology"
DOI: 10.1007/s12254-017-0363-z
Abstract: Inhibition of angiogenesis became clinical reality in 2004 with the approval of bevacizumab in metastatic colorectal cancer and we are now approaching the expiration dates of the patents for bevacizumab in the US in July… read more here.
Keywords: concept; angiogenic therapies; cancer entities; cancer ... See more keywords
Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "BMC Cancer"
DOI: 10.1186/s12885-022-09355-0
Abstract: Background Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique remain the gold standard for… read more here.
Keywords: review; cancer entities; different cancer; cancer ... See more keywords